Postnatal maturation of human GABAA receptors measured with positron emission tomography

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 618-626

  Chugani, Diane C ^a   Muzik, Otto ^a   Juhász, Csaba ^a   Janisse, James J ^a   Ager, Joel ^a   Chugani, Harry T ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; FLUMAZENIL;

ADOLESCENT; ADULT; ARTICLE; BRAIN; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; ONTOGENY; POSITRON EMISSION TOMOGRAPHY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RECEPTOR BINDING;

ADOLESCENT; ADULT; AGE FACTORS; BENZODIAZEPINES; BRAIN; CHILD; CHILD, PRESCHOOL; EPILEPSY; HUMANS; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035026384     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1003     Document Type: Article

References (65)

1. 2+ influx in developing neocortex by excitatory and inhibitory neurotransmitrters. Neuron 1991;6:333-344.
2. Owens DF, Boyce LH, Davis MBE, Kriegstein AR. Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated patch recordings and calcium imaging. J Neurosci 1996;16:6414-6423.
3. - co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999;397:251-255.
4. A receptor determined by electron microscope image analysis. J Neurochem 1994;62:815-818.
5. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998;50:291-313.
6. Whiting PJ. The GABA-A receptor gene family: new targets for therapeutic intervention. Neurochem Int 1999;34:387-390.
7. Olsen RW, Sapp DW, Bureau MH, et al. Allosteric actions of central nervous system depressants including anesthetics on subtypes of the inhibitory γ-aminobutyric acid A receptor-chloride channel complex. Ann NY Acad Sci 1991;625:145-154.
8. A receptor channels. Ann Rev Neurosci 1994;17:569-602.
9. A receptors. Adv Biochem Psychopharmacol 1995;48:57-74.
10. Harrison NL, Kugler JL, Jones MV, et al. Positive modulation of human γ-aminobutyric acid type A and glycine receptor by the inhalation anesthetic isoflurane. Mol Pharmacol 1993;44: 628-632.
11. A receptor α4-subunit expression: possible relevance to alcohol dependence. J Neurochem 1997;68:2485-2492.
12. A receptor: a chemically gated ion channel. Biochem J 1988;249:21-32.
13. A receptor α1 and β1 subunits. FEBS Lett 1989;244:361-364.
14. A-benzodiazepine receptors. Trends Pharmacol Sci 1989;10:407-411.
15. A receptors. FASEB J 1990;4:1469-1480.
16. A receptor family: molecular and functional diversity. Cold Spring Harb Symp Quant Biol 1990;55:29-40.
17. Lidow MS, Goldman-Rakic PS, Rakic P. Synchronized over-production of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci USA 1991;88: 10218-10221.
18. A-receptors in the marmoset monkey: expression of distinct subtypes in pre- and postnatal brain. J Comp Neurol 1996;367: 413-430.
19. A receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry. Neuroscience 1998; 85:179-204.
20. A receptor subunit gene expression in developing monkey cerebral cortex. Neuroscience 1999;91:1223-1245.
21. Miller LG, Greenblatt DJ, Roy RB, et al. Chronic benzodiazepine administration: II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acid A receptor complex binding and function. J Pharmacol Exp Ther 1988; 246:177-182.
22. Lopez F, Miller LG, Greenblatt DJ, et al. Chronic administration of benzodiazepmes: V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam. Neuropharmacology 1990;29:237-241.
23. Jewett DM, Mangner TJ, Watkins GL. Captive solvent methods for fast, simple carbon-ll radioalkylations. In: Emram AM, ed. New trends in radiopharmaceutical synthesis, quality assurance and regulatory control. New York: Plenum Press, 1991.
24. Barre L, Debruyne D, Abadie P, et al. A comparison of methods for the separation of [C-11]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans. Appl Radiat Isot 1991;42:435-439.
25. Bertz RJ, Reynolds IJ, Kroboth PD. Effect of neuroactive steroids on [3H]flumazenil binding to the GABAA receptor complex in vitro. Neuropharmacol 1995;34:1169-1175.
26. Koeppe RA, Holthoff VA, Frey KA, et al. Compartmental analysis of [C-11]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991;11:735-744.
27. Alpert NM, Eriksson L, Chang JY, et al. Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography. J Cereb Blood Flow Metab 1984;4:28-34.
28. Niimura K, Muzik O, Chugani DC, et al. [C-11]Flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci. J Nucl Med 1999;40:1985-1991.
29. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993;43:1998-2006.
30. Muzik O, Janisse J, Ager J, et al. A mathematical model for the analysis of cross-sectional brain glucose metabolism data in children. Prog Neuropsychopharmacol Biol Psychiatry 1999;23: 589-600.
31. Chugani DC, Muzik O, Behen ME, et al. Developmental changes in brain serotonin synthesis capacity in autistic and non-autistic children. Ann Neurol 1999;45:287-295.
32. Belsley D. Conditioning diagnostics: collinearity and weak data in regression. New York: John Wiley & Sons; 1991.
33. A receptor subunit for benzodiazepine pharmacology. Nature 1989;338:582-585.
34. A benzodiazepine receptors produced in transfected cells. Science 1989;245:1389-1392.
35. A receptor. J Neurosci 1990;10:2330-2337.
36. A receptors. Mol Pharmacol 1993;43:970-975.
37. A receptors contining γ3 subunits. Eur J Pharmacol Mol Pharmacol 1996;291:301-309.
38. 6-containing receptors. Mol Pharmacol l996;49:253-259.
39. Pappata S, Samson Y, Chavoix C, et al. Regional specific binding of [C-11]Ro 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 1988;8:304-313.
40. Persson A, Ehrin E, Eriksson L, et al. Imaging of [C-11]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res 1985;19:609-622.
41. Abadie P, Baron JC, Bisserbe JC, et al. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. Eur J Pharmacol 1992;213:107-115.
42. Price JC, Mayberg HS, Dannals RF, et al. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [C-11]flumazenil. J Cereb Blood Flow Metab 1993; 13: 656-667.
43. Blomqvist G, Pauli S, Farde L, et al. Maps of receptor binding parameters in the human brain: a kinetic analysis of PET measurements. Eur J Nucl Med 1990;16:257-265.
44. Lassen NA, Bartenstein PA, Lammertsma AA, et al. Benzodiazepine receptor quantification in vivo in humans using [C-11]flumazenil and PET: application of the steady-state principle. J Cereb Blood Flow Metab 1995;15:152-165.
45. Delforge J, Spelle L, Bendriem B, et al. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. J Cereb Blood Flow Metab 1997;17:343-355.
46. Muzik O, da Silva EA, Juhasz C, et al. lntracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000;54:171-179.
47. Ferrarese C, Cogliati T, Tortorella R, et al. Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res 1998;29:129-134.
48. Baxter LR, Mazziotta JC, Phelps ME, et al. Cerebral glucose metabolic rates in normal human females versus normal males. Psychiatry Res 1987;21:237-245.
49. Gur RC, Gur RE, Obrist WD, et al. Sex and handedness difference in cerebral blood flow during rest and cognitive activity. Science 1982;217:256-261.
50. Chugani DC, Muzik O, Chakraborty PK, et al. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse 1998;28:33-43.
51. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol 1987;22:487-497.
52. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997; 387:167-178.
53. Chugani HT, Hovda DA, Villablanca JR, et al. Metabolic maturation of the brain: a study of local cerebral glucose utilization in the developing cat. J Cereb Blood Flow Metab 1991;11:35-47.
54. Jacobs B, Chugani HT, Allada V, et al. Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography. Cerebral Cortex 1995;3:222-233.
55. Huttenlocher PR, de Courten C, Garey LJ, Van der Loos H. Synaptogenesis in human visual cortex: evidence for synapse elimination during normal development. Neurosci Lett 1982; 33:247-252.
56. Huttenlocher PR, de Courten C. The development of synapses in the striate cortex of man. Hum Neurobiol 1987;6:1-9.
57. Wolf W, Hicks TP, Albus K. The contribution of GABA-mediated inhibitory mechanisms to visual response properties of neurons in the kitten's striate cortex. J Neurosci 1986;6:2779-2796.
58. Ramoa AS, Paradiso MA, Freeman RD. Blockade of intracortical inhibition in kitten striate cortex: effects on receptive field properties and associated loss of ocular dominance plasticity. Exp Brain Res 1988;73:285-298.
59. Reiter HO, Stryker MP. Neural plasticity without postsynaptic action potentials: less active inputs become dominant when kitten visual cortical cells are pharmacologically inhibited. Proc Natl Acad Sci USA 1988;85:3623-3627.
60. A receptor mRNAs in monkey visual cortex. J Neurosci 1994;14: 2236-2259.
61. Huang ZJ, Kirkwood A, Pizzorusso T, et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999;98:739-755.
62. A receptor subunit and GAD genes in mouse somatosensory barrel cortex. J Comp Neurol 1997;383:199-219.
63. A receptor subunit mRNAs in monkey sensory motor cortex. J Comp Neurol 1995;362:565-582.
64. Carlson BX, Elster L, Schousboe A. Pharmacological and functional implications of developmentally-regulated changes in GABA(A) receptor subunit expression in the cerebellum. Eur J Pharmacol 1998;352:1-14
65. Hensch TK, Fagiolini M, Mataga N, et al. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998;282:1504-1508.